Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...

Kyle Larson Defends NASCAR's $2.3 Billion Partner With a 3-Word Advice for Fans' Bristol Backlash Rock star plans to keep sharing faith message at concerts: 'Greatest thing...I can do with my platform ...

New research conducted at Columbia Mailman School of Public Health and Mount Sinai School of Medicine shows a link between prediabetes among young people and adverse pregnancy outcomes later in life.

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

A 10% higher intake of ultra-processed foods like savory snacks, animal-based products, and ready-to-eat meals is associated ...

St. Louis-based diabetes treatment startup Aegis Digital Health is nearing $1 million in its latest funding round and seeing ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.

The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised ...

Personalized weight loss programs in obese children are shown to reduce specific harmful lipids linked to heart disease and ...